{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:12Z","timestamp":1791996072309,"version":"4.4.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41433-025-04130-4","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T10:35:23Z","timestamp":1764930923000},"page":"165-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proportion of patients with Demodex blepharitis in ophthalmology clinics in Europe: the Eos study"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0667-3700","authenticated-orcid":false,"given":"Mayank A.","family":"Nanavaty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Findl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Carones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheraz M.","family":"Daya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Geerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-9585","authenticated-orcid":false,"given":"Thomas","family":"Kohnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil D.","family":"Kurniawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lockington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik L.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Nubile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Rampat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Hajjar Ses\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shahnazaryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Yeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Burkhard","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"4130_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/ICL.0000000000001003","volume":"49","author":"MK Rhee","year":"2023","unstructured":"Rhee MK, Yeu E, Barnett M, Rapuano CJ, Dhaliwal DK, Nichols KK, et al. Demodex blepharitis: a comprehensive review of the disease, current management, and emerging therapies. Eye Contact Lens. 2023;49:311\u20138.","journal-title":"Eye Contact Lens"},{"key":"4130_CR2","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.2147\/OPTH.S374530","volume":"16","author":"L O\u2019Dell","year":"2022","unstructured":"O\u2019Dell L, Dierker DS, Devries DK, Garlich J, Whitley WO, Holdbrook M, et al. Psychosocial impact of demodex blepharitis. Clin Ophthalmol Auckl Nz. 2022;16:2979\u201387.","journal-title":"Clin Ophthalmol Auckl Nz"},{"key":"4130_CR3","first-page":"3952","volume":"63","author":"K Snyder","year":"2022","unstructured":"Snyder K, Mah F, Nattis A, Rosenberg E, Yeu E. Demodex blepharitis and coexisting bacterial burden in Eye care patients: the Pandora study. Invest Ophthalmol Vis Sci. 2022;63:3952\u2013A0232.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4130_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2147\/OPTH.S354692","volume":"16","author":"W Trattler","year":"2022","unstructured":"Trattler W, Karpecki P, Rapoport Y, Sadri E, Schachter S, Whitley WO, et al. The prevalence of demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol Auckl Nz. 2022;16:1153\u201364.","journal-title":"Clin Ophthalmol Auckl Nz"},{"key":"4130_CR5","first-page":"3249","volume":"37","author":"BD Ayres","year":"2023","unstructured":"Ayres BD, Donnenfeld E, Farid M, Gaddie IB, Gupta PK, Holland E, et al. Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH). Eye Lond Engl. 2023;37:3249\u201355.","journal-title":"Eye Lond Engl"},{"key":"4130_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/13696998.2025.2500224","volume":"28","author":"LM Periman","year":"2025","unstructured":"Periman LM, Whitley WO, Maiti S, Mun J, Ho AN, Oak B, et al. The patient journey and burden of disease in Demodex blepharitis in the United States. J Med Econ. 2025;28:734\u201342.","journal-title":"J Med Econ"},{"key":"4130_CR7","first-page":"1236","volume":"62","author":"A Teo","year":"2021","unstructured":"Teo A, Rosenberg E, Jacobson A. Prevalence of demodex colonization in patients presenting to an outpatient clinic. Invest Ophthalmol Vis Sci. 2021;62:1236.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4130_CR8","unstructured":"Suzuki T, Kinoshota S, Arita R, Dhamdere K. Prevalence of demodex blepharitis in Japan: The Elara study. In: Los Angeles; 2025. Available at: https:\/\/ascrs.confex.com\/ascrs\/25am\/meetingapp.cgi\/Paper\/111999."},{"key":"4130_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2019.03.007","volume":"204","author":"DF Rabensteiner","year":"2019","unstructured":"Rabensteiner DF, Aminfar H, Boldin I, Nitsche-Resch M, Berisha B, Schwantzer G, et al. Demodex mite infestation and its associations with tear film and ocular surface parameters in patients with ocular discomfort. Am J Ophthalmol. 2019;204:7\u201312.","journal-title":"Am J Ophthalmol"},{"key":"4130_CR10","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.2147\/OPTH.S407898","volume":"17","author":"C Boel","year":"2023","unstructured":"Boel C, Westerveld E, Kloos D, Goezinne F. Refining the diagnostic technique to determine prevalence of demodex mites in eyelash hair follicles within standard ophthalmic practice: a single-center outpatient clinical study. Clin Ophthalmol Auckl Nz. 2023;17:2027\u201336.","journal-title":"Clin Ophthalmol Auckl Nz"},{"key":"4130_CR11","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2147\/OPTH.S525681","volume":"19","author":"E Donnenfeld","year":"2025","unstructured":"Donnenfeld E, Nichols K, Ayres B, Farid M, Gupta P, Lindstrom R, et al. The demodex expert panel on treatment and eyelid health (DEPTH) consensus regarding the preferred treatment for demodex blepharitis. Clin Ophthalmol. 2025;19:1893\u2013904.","journal-title":"Clin Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04130-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:37:49Z","timestamp":1769168269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04130-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4130"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04130-4","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EY is an employee and shareholder of Tarsus. All other authors are consultants for Tarsus Pharmaceuticals Inc. and received consultancy fees in relation to this project. Mayank A. Nanavaty is also a consultant to Alcon, Bausch + Lomb, HOYA and Johnson & Johnson & he is a member of Eye Editorial board. Oliver Findl is also a scientific advisor to Carl Zeiss Meditec AG, Croma Pharma GmbH and Johnson & Johnson. SD has also received grant support from Allotex and Johnson & Johnson Vision; is a consultant and\/or has received lecture fees from Bausch + Lomb, BVI-PhysIOL, Nidek Inc, Carl Zeiss Meditec, Cristalens, Excel-Lens, Infinite Medical Ventures, Lumenis Vision, Ocuphire Pharma, Oyster Point Pharma, PRN nutraceuticals and ViaLase; and owns equity in Excel-Lens, Infinite Medical Ventures and PRN nutraceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}